For hypertensive children and adolescents participating in sports, long-acting ACE inhibitors or calcium channel blockers are preferred to avoid reducing exercise tolerance.
Answers are grounded in this paper and cite their sources.
Supports preference for long-acting ACE inhibitors or CCBs in hypertensive youth athletes; leaves open need for prospective trials before practice change.
In brief For hypertensive children and adolescents who participate in sports, hygienic interventions may already be adequate-or may be unachievable. Yet, the decision to initiate pharmacotherapy is difficult. Physicians must weigh factors such as the presence of end-organ damage or a family history of early hypertensive complications with possible adverse effects of antihypertensive drugs, including depressant effects on the heart and reduced exercise tolerance. The authors favor long-lasting ACE inhibitors or calcium channel blockers, which usually do not alter heart rate and are relatively free of side effects.
No takes yet. Share an insight, caveat, or question.
Daniels et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: